Best of Oncology Podcast Series

Moving Towards Personalized Approach In Multiple Myeloma

This program was made possible by unrestricted sponsorship support from Amgen.

Multiple Myeloma: Treatment at First Relapse

BOOE 2020 - Lunch Symposium (Mylan) - The Future of Biosimilars in Oncology - Implementing the Lessons from Today

BOOE 2020 - Breast Cancer

BOOE 2020 - Radiation Oncology Update: Management of Oligometastases

BOOE 2020 - GU - Prostate and Non-Prostate

BOOE 2020 - Melanoma

BOOE 2020 - Lung Cancer

Speaker: Dr. Barry Stein Chair: Dr. Sharlene Gill

How to Communicate Treatment Choices for mCRC - A Physician and Patient Perspective

Featuring Dr. Dr. Marcus Butler, Dr. Michael Smylie, and Dr. Jason Luke Trials Discussed:    Metastatic/Advanced Melanoma: COMBI-i Trial, LEAP-004 and SECOMBIT  Adjuvant Trials in Melanoma: KEYNOTE 054 and CheckMate 238 Metastatic/Advanced Melanoma: Local Therapy in Solitary Melanoma, NIVO+IPI vs NIVO and ILLUMINATE-204  Non-Melanoma Skin Cancer: PD1 Blockage in Kaposi Sarcoma This podcast has been made available through sponsorship from BMS.  

Highlights from ESMO 2020: Skin Cancer (Melanoma and Non-Melanoma)

Featuring Dr. Barbara Melosky, Dr. Parneet Cheema, and Dr. Peter Ellis.  Trials Discussed:    Presidential Symposiums: CROWN, ADAURA, and Lung Art Metastatic NSCLC: ZENITH20 and TAK-788 Metastatic NSCLC & EGFR Drug Conjugates: Amivantamab & Lazertinib and Patritumab Deruxtecan Stage III NSCLC: 4-year survival of PACIFIC trial Neoadjuvant Trials: durvalumab in NSCLC and PRINCEPS trial This podcast has been made available through sponsorship from Amgen.

Highlights from ESMO 2020: Lung Cancer

Featuring Dr. Srikala Sridhar, Dr. Sebastien Hotte, and Dr. Petros Grivas  Trials Discussed:    Bladder Cancer: KEYNOTE-361, DANUBE and TROPHY-U-01 Cohort 1 Kidney/Prostate Cancer: CheckMate-9ER and COSMIC Prostate Cancer: IPATential150, PROfound and STAMPEDE  This podcast has been made available through sponsorship from BMS and Ipsen.  

Highlights from ESMO 2020: GU Cancer

Featuring Dr. Scott Berry, Dr. Sharlene Gill and Dr. Marc Peeters Trials Discussed:   Gastroesophageal Cancer: CheckMate 649, ATTRACTION-4, KEYNOTE-062, KEYNOTE-590, and CheckMate 577 GI Colorectal: KEYNOTE-177 and PRODIGE 13 This podcast has been made available through sponsorship by Amgen and BMS.  

Highlights from ESMO 2020: GI Cancer

Featuring Dr. Heather McArthur, Dr. Erika Hamilton and Dr. Fabrice André.  Trials Discussed:  HR+ MBC: SOLAR-1 and nextMONARCH  EARLY HR+ DISEASE: Monarch E and PALLAS  TNBC: IMpassion130, IMpassion131, IMpassion031 and ASCENT 

Highlights from ESMO 2020: Breast Cancer

Featuring:  Dr. Bruce Colwell (Chair) Dr. Rachel Goodwin  This podcast has been made available through unrestricted sponsorship support from Amgen. Learning Objectives:  Discuss the evidence that supports current mCRC treatment recommendations Discuss treatment attrition and how it may impact clinical practice Describe the challenges to implement evidence based medicine and ways to overcome them 

How do I treat mCRC in Canada? Translating the evidence to local clinical practice

Welcome to the Best of Oncology podcast series, brought to you by OncologyEducation. Join our medical oncology experts as they discuss clinical implications of the latest advances and the hottest topics in the treatment and management of cancer.

hubhopper

Best of Oncology Podcast Series

hubhopper